Articles

Bad executors, greedy friends, inheritances, elder abuse and qualifying for Medicaid featured as the most-read Moneyist columns of the year.

Volatility is not the typical retirement investor’s friend.

Why the stock market’s odds of rising in 2026 are the same regardless of seasonal indicators.

Bullish technical indicators are breaking down.

Insider share ownership and corporate profitability are key to finding stocks that have been temporarily sold off.

Beyond the biggest chains, the past few years have largely been ones to forget for retailers, as shoppers have remained wary about spending amid a battle with higher living costs. Yet some analysts see a path toward a slightly better 2026.

Tesla’s rough year took it to its second straight annual sales decline, and saw it lose its global EV sales leadership to China’s BYD.

Valuation indicators now are extremely bearish for U.S. stocks. Non-U.S. stocks are a much better bet.

China controls around 70% of the silver that Big Tech, AI and solar power desperately need. Beijing is locking the gates.

How to trim your tax bill when taking RMDs.

A six-state pilot program will target “wasteful care” under Medicare, Centers for Medicare & Medicaid Services says.

Also, new artificial-intelligence reviews for Medicare approvals and an opportunity in the stock market for early 2026